510(k) Report

510(k) · Cleared

Cleared

Calcigen Psi Bone Graft Substitute

K032286510(k) TraditionalCleared Nov 20, 2003119-day reviewClass II21 CFR 888.3045

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Biomet Orthopedics, Inc. · MQV Filler, Bone Void, Calcium Compound

Cleared on Nov 20, 2003 as substantially equivalent to K030178 (Biomet, Inc., 2003) and 3 other predicates after a 119-day review. Its family tree reaches back 4 generations to 1996. 1 later device descends from it.

Decided
Nov 20, 2003
Review
119 days
Class
Class II
Product code
MQV
Recalls
None
Predicates
4

Its longest line of descent runs back 4 generations to K960978 (1996). 15 ancestors in all. 1 later device descends from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2003: 1 other ancestor2002: 6 other ancestors2001: 1 other ancestor2000: 1 other ancestor1999: 1 other ancestor1997: 1 other ancestor2007: 1 descendant clearedK960978 · Wright Plaster of Paris Pellets (Subject to Revision) · Wrightmedicaltechnologyinc · 1996K980817 · Pro Osteon Implant 500R Resorbable Bone Graft Substitute Model Numbers 5RG05, 5RG10, 5RG15, 5G15L, 5RG20, 5RG30, 5RG30L · Interpore Intl. · 1998K013960 · Apatight HA-Bone Graft Substitute · Cerabio, LLC · 2002K030178 · Calcigen Psi Bone Graft Substitute · Biomet, Inc. · 20031995200020052010201520202025
  1. Root · 4 generations backK960978 Wright Plaster of Paris Pellets (Subject to Revision)Wrightmedicaltechnologyinc · 1996
  2. 3 generations backK980817 Pro Osteon Implant 500R Resorbable Bone Graft Substitute Model…Interpore Intl. · 1998
  3. 2 generations backK013960 Apatight HA-Bone Graft SubstituteCerabio, LLC · 2002
  4. 1 generation backK030178 Calcigen Psi Bone Graft SubstituteBiomet, Inc. · 2003
  5. This deviceK032286 Calcigen Psi Bone Graft SubstituteBiomet Orthopedics, Inc. · 2003
  6. Descendant · cites it directly · 0 of its ownK063346 Pro Osteon 500REbi, L.P. · 2007

Most influential descendants

Showing 1 of 1 · See all
  • K063346Pro Osteon 500REbi, L.P. · 2007 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K960978Wright Plaster of Paris Pellets (Subject to Revision)Wrightmedicaltechnologyinc1996—
−3K980817Pro Osteon Implant 500R Resorbable Bone Graft Substitute Model Numbers 5RG05…Interpore Intl.1998—
−2K013960Apatight HA-Bone Graft SubstituteCerabio, LLC2002—
−1K030178Calcigen Psi Bone Graft SubstituteBiomet, Inc.2003—
0 (this device)K032286Calcigen Psi Bone Graft SubstituteBiomet Orthopedics, Inc.2003—
+1K063346Pro Osteon 500REbi, L.P.2007—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199710
199910
200010
200110
200260
200310

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200710
FIG. 1 — Lineage of K032286, 1996–2007Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MQV? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MQV device

  1. #1 K232315 Catalyst Bone Void Fillerscore 25.2 · 25 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (4)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K030178Calcigen Psi Bone Graft SubstituteBiomet, Inc.2003—
*K022629WMT-TCP Bone Graft SubstituteWrightmedicaltechnologyinc2002—
*K014156Cerasorb OrthoCurasan AG2002—
*K024336Miig II Bone Graft SubstituteWrightmedicaltechnologyinc2003—

Also cleared against K030178: 1 other device →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K063346Pro Osteon 500REbi, L.P.20070

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 7 years and passes through 5 companies; a new generation was cleared every 2.3 years on median.
  • None of the 15 ancestors has a recall.
  • Of its descendants, K063346 (Ebi, L.P., 2007) has gone furthest, with 0 descendants of its own.
  • 1 other device also cites its predicate K030178.

How does its category compare?

All MQV devices

MQV Filler, Bone Void, Calcium Compound: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · MQV

14in 2025

2007: 352008: 322009: 232010: 172011: 162012: 92013: 122014: 202015: 182016: 82017: 172018: 232019: 132020: 152021: 82022: 92023: 212024: 282025: 142026 (partial year): 5
2007high 35 (2007) · low 8 (2016)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MQV

57in 2025

2007: 144 days median2008: 102 days median2009: 180 days median2010: 147 days median2011: 92 days median2012: 107 days median2013: 197 days median2014: 153 days median2015: 184 days median2016: 214 days median2017: 124 days median2018: 124 days median2019: 90 days median2020: 132 days median2021: 88 days median2022: 118 days median2023: 74 days median2024: 55 days median2025: 57 days median2026 (partial year): 96 days median
2007high 214 (2016) · low 55 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MQV

1in 2025

2007: 52008: 32009: 12011: 62012: 32013: 22016: 12017: 12018: 22020: 12023: 32024: 22025: 12026 (partial year): 4
2007high 6 (2011) · low 0 (2010)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MQV

57in 2025

2007: 672008: 712009: 812010: 682011: 1142012: 1492013: 2232014: 1112015: 1252016: 1062017: 1072018: 862019: 652020: 1262021: 1012022: 472023: 1202024: 682025: 57
2007high 223 (2013) · low 47 (2022)2025

MAUDE reports naming product code MQV, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200735144567
200832102371
200923180181
201017147068
201116926114
201291073149
2013121972223
2014201530111
2015181840125
201682141106
2017171241107
201823124286
20191390065
2020151321126
20218880101
20229118047
202321743120
20242855268
20251457157
20265964—

What is it indicated for?

CalcigenTMPSI bone graft substitute is indicated for bony voids or gaps of the skeletal system (i.e., the extremities, spine and pelvis) that are not intrinsic to the stability of the bony structure. These defects may be surgically created osseous defects or osseous defects created from disease or traumatic injury to the bone. CalcigenTMPSI bone graft substitute can be combined with autogeneous bone marrow aspirate or autogenous blood. CalcigenTMPSI resorbs and is replaced with bone during the healing process.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K032286: Calcigen Psi Bone Graft Substitute.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K032286

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026